Prevalence of Anti-HIV and Anti-delta Among Deferred HBsAg-Positive Volunteer Blood Donors

  1. MARIA D. DEMEDINA, M.S.P.H.;
  2. LENNOX J. JEFFERS, M.D.;
  3. K. RAJENDER REDDY, M.D.;
  4. STEVE Y. VILLANUEVA, M.D.;
  5. WENDY BRENDEL, MT(ASCP)SBB;
  6. BRUCE LENES, M.D.;
  7. PETER TOMASULO, M.D.; and
  8. EUGENE R. SCHIFF, M.D.
  1. Veterans Administration Medical Center; University of Miami School of Medicine; American Red Cross Blood Services,
    South Florida Region; Miami, FL 33101

    Excerpt

    To the editor: Concomitant infection with the human immunodefiency virus (HIV) or delta infection among asymptomatic blood donors positive for hepatitis B surface antigen (HBsAg) has not been well characterized. Therefore, an unlinked study to determine existing parallels in the prevalence of anti-HIV and anti-delta among deferred positive HBsAg asymptomatic volunteer blood donors was done. Donors were screened at the American Red Cross-South Florida Region from April 1984 to June 1985. Fifty-five percent of the volunteer blood donors were men and 45% women. Hepatitis B surface antigen, anti-delta, and anti-HIV were determined by commercially available enzyme-linked immunoassay (Abbott Laboratories, North

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement